The Role of Inflammation in Ocular Tumours

Status Recruiting

Clinical Trial Summary

This prospective, non-therapeutic study will determine whether a novel imaging technique can identify presumptive tumour associated macrophages (TAMs) in patients with ocular tumours.

The investigators will evaluate 5 groups:

1. Choroidal nevus

2. Choroidal indeterminate melanocytic lesion

3. Choroidal melanoma

4. Suspected metastatic tumour (ie, primary tumour elsewhere)

5. Locally treated ocular tumours

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02909517
Study type	Observational
Source	St. Michael's Hospital, Toronto
Contact	Emily Mathieu, PhD
Phone	4168646060
Email	mathieue@smh.ca
Status	Recruiting
Phase
Start date	March 2016
Completion date	May 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04364230` - Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma)	Phase 1/Phase 2
Completed	`NCT01200238` - STA-9090(Ganetespib) in Metastatic Ocular Melanoma	Phase 2
Active, not recruiting	`NCT02858869` - Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases	Phase 1
Completed	`NCT01355120` - THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease	Phase 2
Recruiting	`NCT05524935` - Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma	Phase 2
Recruiting	`NCT05628883` - Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma	Phase 1
Active, not recruiting	`NCT05187884` - Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma	Phase 2
Withdrawn	`NCT00621439` - Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye	N/A
Terminated	`NCT00346372` - Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Recruiting	`NCT03172299` - Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma	Phase 3
Completed	`NCT01893099` - Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma	Phase 1
Completed	`NCT00351728` - Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone	N/A
Active, not recruiting	`NCT03528408` - Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma	Phase 2
Completed	`NCT03052127` - Study in Subjects With Small Primary Choroidal Melanoma	Phase 1/Phase 2
Withdrawn	`NCT01930968` - Definity for Ultrasound of Intraocular Tumors
Recruiting	`NCT00168870` - Study of Metastatic Ocular Melanoma	Phase 2
Completed	`NCT02519322` - Neoadjuvant and Adjuvant Checkpoint Blockade	Phase 2
Recruiting	`NCT06007690` - A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma	Phase 3
Active, not recruiting	`NCT04417530` - Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma	Phase 2
Completed	`NCT02129075` - A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma	Phase 2